Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Thromboprophylaxis With Low Molecular Weight Heparin in Critically Ill Patients With COVID-19. A Prospective, Cohort, Multicenter Study.

NCT04623177 is registered in ClinicalTrials.gov with Instituto de Investigacion Sanitaria La Fe as lead sponsor.

NCT NCT04623177
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04623177 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Thromboprophylaxis With Low Molecular Weight Heparin in Critically Ill Patients With COVID-19. A Prospective, Cohort, Multicenter Study.
Lead sponsor
Instituto de Investigacion Sanitaria La Fe
Phase
Observational
Overall status
Completed
Start date
March 1, 2020
Completion date
November 30, 2020
Enrollment
822 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant therapy, covid19, thrombosis